Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × Axitinib × Clear all

NCT03386929 2023-12-18

SPRING

Phase 1/2 Terminated

15 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT04459663 2020-07-07

JS001 Combination Therapy in NSCLC Negative Driving Gene After First-line Chemotherapy.

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung